Medicare does not typically cover ketamine infusions for mental health conditions. However, it may cover Spravato, an FDA-approved drug deriving from ketamine, for treatment-resistant depression.
It is commonly used to boost the immune system or treat immune-related disorders. Johnson said the treatment would follow a bi-weekly protocol, including two TPE sessions followed by IVIG infusions ...
The "Vodka Market Report by Type, Quality, Distribution Channel, and Region 2025-2033" report has been added to ResearchAndMarkets.com's offering.The global vodka market size reached USD 50.3 billion ...